Clinical Trials Browser

Pancreatic Neoplasms × nimotuzumab × 1 year × Clear all

NCT06770452 2025-09-23

HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms